v3.25.1
Condensed Consolidated Balance Sheet (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash, cash equivalents and current restricted cash $ 435,999 $ 431,936
Accounts receivable, net 96,150 118,017
Inventory, net 64,001 56,797
Other current assets and prepaid expenses 54,441 55,339
Assets held for sale 87,013 0
Total current assets 737,604 662,089
Property, Plant and Equipment, Net 71,195 70,134
Intangible assets, net 568,518 616,613
In-process research and development 195,000 195,000
Goodwill 476,672 529,252
Investments 12,750 54,584
Operating lease right-of-use assets 47,819 54,003
Other assets 18,769 18,537
Total assets 2,128,327 2,200,212
Liabilities, Current [Abstract]    
Accounts payable 59,370 47,071
Accrued Liabilities, Current 113,209 118,357
Current maturities of operating leases 9,888 12,649
Current portion of convertible notes 101,242 170
Current portion of lines of credit and notes payable 12,145 14,849
Total current liabilities 295,854 193,096
Operating lease liabilities 38,344 48,849
Long term portion of convertible notes 77,226 173,606
Senior secured notes 245,794 245,576
Deferred tax liabilities 129,435 140,799
Other Liabilities, Noncurrent 30,011 32,838
Total long-term liabilities 520,810 641,668
Total liabilities 816,664 834,764
Equity:    
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 701,406,697 and 701,350,447 shares issued at March 31, 2025 and December 31, 2024, respectively 7,015 7,015
Treasury Stock - 29,799,907, and 29,799,907 shares at March 31, 2025 and December 31, 2024, respectively (1,791) (1,791)
Additional paid-in capital 3,484,068 3,481,364
Accumulated other comprehensive loss (45,006) (56,130)
Accumulated deficit (2,132,623) (2,065,010)
Total shareholders’ equity 1,311,663 1,365,448
Total liabilities and equity $ 2,128,327 $ 2,200,212

Source

HTML PDF
ZIP